COVID-flu shot offers strong immune response in late-stage trial, Moderna says
Moderna says it combination vaccine to protect against both COVID-19 and influenza generated a stronger immune response in adults 50 and over when compared to separate shots.
![COVID-flu shot offers strong immune response in late-stage trial, Moderna says](https://globalnews.ca/wp-content/uploads/2022/06/20220608070644-62a08c6098ae023880f20346jpeg.jpg?quality=85&strip=all&w=720&h=480&crop=1#)
![](https://globalnews.ca/wp-content/uploads/2022/06/20220608070644-62a08c6098ae023880f20346jpeg.jpg?quality=85&strip=all&w=720&h=480&crop=1)
Moderna says it combination vaccine to protect against both COVID-19 and influenza generated a stronger immune response in adults 50 and over when compared to separate shots.